Chiesi USA, Inc. recalls CUROSURF (poractant alfa)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- CUROSURF (poractant alfa)
- Company
- Chiesi USA, Inc.
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 7,235 vials
- About this recall
- CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.